"Liver Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes of the LIVER.
| Descriptor ID |
D008107
|
| MeSH Number(s) |
C06.552
|
| Concept/Terms |
Liver Diseases- Liver Diseases
- Disease, Liver
- Diseases, Liver
- Liver Disease
Liver Dysfunction- Liver Dysfunction
- Dysfunction, Liver
- Dysfunctions, Liver
- Liver Dysfunctions
|
Below are MeSH descriptors whose meaning is more general than "Liver Diseases".
Below are MeSH descriptors whose meaning is more specific than "Liver Diseases".
This graph shows the total number of publications written about "Liver Diseases" by people in this website by year, and whether "Liver Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 3 | 0 | 3 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 2 | 3 |
| 2002 | 5 | 2 | 7 |
| 2003 | 1 | 5 | 6 |
| 2004 | 4 | 0 | 4 |
| 2005 | 3 | 1 | 4 |
| 2006 | 2 | 2 | 4 |
| 2007 | 8 | 4 | 12 |
| 2008 | 6 | 1 | 7 |
| 2009 | 6 | 3 | 9 |
| 2010 | 6 | 0 | 6 |
| 2011 | 9 | 2 | 11 |
| 2012 | 4 | 1 | 5 |
| 2013 | 3 | 2 | 5 |
| 2014 | 7 | 3 | 10 |
| 2015 | 8 | 1 | 9 |
| 2016 | 3 | 1 | 4 |
| 2017 | 8 | 0 | 8 |
| 2018 | 11 | 0 | 11 |
| 2019 | 13 | 1 | 14 |
| 2020 | 7 | 2 | 9 |
| 2021 | 12 | 0 | 12 |
| 2022 | 13 | 0 | 13 |
| 2023 | 13 | 0 | 13 |
| 2024 | 2 | 5 | 7 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Diseases" by people in Profiles.
-
Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015-2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Hum Vaccin Immunother. 2025 Dec; 21(1):2457205.
-
Training robust T1-weighted magnetic resonance imaging liver segmentation models using ensembles of datasets with different contrast protocols and liver disease etiologies. Sci Rep. 2024 09 09; 14(1):20988.
-
Advanced cystic fibrosis liver disease: Endovascular, endoscopic, radiologic, and surgical considerations. Pediatr Pulmonol. 2024 Sep; 59 Suppl 1:S115-S122.
-
Liver disease and transplantation in telomere biology disorders: An international multicenter cohort. Hepatol Commun. 2024 07 01; 8(7).
-
Natural history study of hepatic glycogen storage disease type IV and comparison to Gbe1ys/ys model. JCI Insight. 2024 May 14; 9(12).
-
SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium. Pediatr Pulmonol. 2024 Jun; 59(6):1661-1676.
-
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity? Gut. 2024 04 05; 73(5):721-724.
-
Homozygous missense variants in YKT6 result in loss of function and are associated with developmental delay, with or without severe infantile liver disease and risk for hepatocellular carcinoma. Genet Med. 2024 Jul; 26(7):101125.
-
Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2025 Feb 01; 81(2):725-748.
-
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement. Hepatol Commun. 2024 02 01; 8(2).